Actelis Networks Inc. (ASNS) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Actelis Networks Inc. stock (ASNS) is currently trading at $0.38. Actelis Networks Inc. PS ratio (Price-to-Sales) is 0.74. Analyst consensus price target for ASNS is $5.00. WallStSmart rates ASNS as Sell.
- ASNS PE ratio analysis and historical PE chart
- ASNS PS ratio (Price-to-Sales) history and trend
- ASNS intrinsic value — DCF, Graham Number, EPV models
- ASNS stock price prediction 2025 2026 2027 2028 2029 2030
- ASNS fair value vs current price
- ASNS insider transactions and insider buying
- Is ASNS undervalued or overvalued?
- Actelis Networks Inc. financial analysis — revenue, earnings, cash flow
- ASNS Piotroski F-Score and Altman Z-Score
- ASNS analyst price target and Smart Rating
Actelis Networks Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Actelis Networks Inc. (ASNS) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Actelis Networks Inc. (ASNS) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
Actelis Networks Inc. (ASNS) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -74.70%, a shrinking business
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Low institutional interest, mostly retail-driven
Actelis Networks Inc. (ASNS) Detailed Analysis Report
Overall Assessment
This company scores 30/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 1.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.74), Price/Book (0.84) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -74.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -260.10%, Operating Margin at -311.40%, Profit Margin at -223.90%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -260.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -74.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ASNS Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ASNS's Price-to-Sales ratio of 0.74x trades 39% below its historical average of 1.21x (33th percentile). The current valuation is 78% below its historical high of 3.32x set in Jun 2024, and 288% above its historical low of 0.19x in Feb 2026.
Compare ASNS with Competitors
Top COMMUNICATION EQUIPMENT stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Actelis Networks Inc. (ASNS) · TECHNOLOGY › COMMUNICATION EQUIPMENT
The Big Picture
Actelis Networks Inc. is in a turnaround phase, with management focused on restoring profitability. Revenue reached 3M with 75% decline year-over-year. The company is currently unprofitable, posting a -223.9% profit margin.
Key Findings
Spending 21% of revenue (691,000) on R&D, reinforcing its commitment to innovation and future growth.
Revenue contracted 75% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -223.9% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Volatility is elevated with a beta of 2.25, so expect amplified moves relative to the broader market.
Sector dynamics: monitor COMMUNICATION EQUIPMENT industry trends, competitive moves, and regulatory changes that could impact Actelis Networks Inc..
Bottom Line
Actelis Networks Inc. is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:23:22 AM
About Actelis Networks Inc.(ASNS)
NASDAQ
TECHNOLOGY
COMMUNICATION EQUIPMENT
USA
Arsanis, Inc., a clinical-stage biopharmaceutical company, focuses on applying monoclonal antibody (mAb) immunotherapies to treat infectious diseases. The company is headquartered in Waltham, Massachusetts.